EZH2 in hepatocellular carcinoma: progression, immunity, and potential targeting therapiesBohan Wang, Lei Zhang, Bixiang Zhang et al.|Experimental Hematology and Oncology|2023Cited by 53
Hepatitis B surface antigen: carcinogenesis mechanisms and clinical implications in hepatocellular carcinomaBingtao Hao, L Zhang, Yachong Liu et al.|Experimental Hematology and Oncology|2025Cited by 12